Search results for "Positron-emission tomography"

showing 10 items of 228 documents

Predicting the in vivo release from a liposomal formulation by IVIVC and non-invasive positron emission tomography imaging

2010

This study aimed to predict the in vivo performance from the in vitro release of a low-molecular weight model compound, [(18)F]-2-fluoro-2-deoxy-d-glucose ([(18)F]FDG), from liposomes and by means of positron emission tomography (PET). Liposomes composed of hydrogenated phosphatidylcholine (HPC) were prepared by a freeze-thaw method. Particle size distribution was measured by dynamic light scattering (DLS). In vitro release was examined with a dispersion method detecting the radioactivity of [(18)F]FDG. In vivo release of [(18)F]FDG, following i.p. injection of the liposomes in rats, was determined by using a Micro-PET scanner. Convolution was performed to predict the in vivo profiles from …

Liposomemedicine.diagnostic_testbusiness.industryPharmaceutical SciencePharmaceutical formulationModified Release Dosage FormRatschemistry.chemical_compoundIVIVCchemistryDynamic light scatteringFluorodeoxyglucose F18Positron emission tomographyIn vivoPositron-Emission TomographyPhosphatidylcholineLiposomesmedicineAnimalsParticle SizeNuclear medicinebusinessBiomedical engineeringEuropean Journal of Pharmaceutical Sciences
researchProduct

A smart and operator independent system to delineate tumours in Positron Emission Tomography scans

2018

Abstract Positron Emission Tomography (PET) imaging has an enormous potential to improve radiation therapy treatment planning offering complementary functional information with respect to other anatomical imaging approaches. The aim of this study is to develop an operator independent, reliable, and clinically feasible system for biological tumour volume delineation from PET images. Under this design hypothesis, we combine several known approaches in an original way to deploy a system with a high level of automation. The proposed system automatically identifies the optimal region of interest around the tumour and performs a slice-by-slice marching local active contour segmentation. It automa…

Lung NeoplasmsComputer sciencemedicine.medical_treatmentPET imagingPattern Recognition Automated030218 nuclear medicine & medical imaging0302 clinical medicineNeoplasmsImage Processing Computer-AssistedSegmentationDiagnosis Computer-AssistedNeoplasm MetastasisRadiation treatment planningSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniObserver VariationActive contour modelmedicine.diagnostic_testBrain NeoplasmsPhantoms ImagingComputer Science ApplicationsHead and Neck NeoplasmsPositron emission tomography030220 oncology & carcinogenesis18F-fluoro-2-deoxy-d-glucoseAlgorithms18F-fluoro-2-deoxy-d-glucose and 11C-labeled methionine PET imagingSimilarity (geometry)Health InformaticsSensitivity and SpecificityNOActive contour algorithm03 medical and health sciencesFluorodeoxyglucose F18Predictive Value of TestsRegion of interestmedicineHumansFalse Positive ReactionsRetrospective Studies18F-fluoro-2-deoxy-d-glucose 11C-labeled methionine PET imaging Active contour algorithm Biological target volume Cancer segmentationbusiness.industryRadiotherapy Planning Computer-Assisted11C-labeled methionineReproducibility of ResultsPattern recognitionGold standard (test)Cancer segmentationRadiation therapyBiological target volumePositron-Emission TomographyArtificial intelligenceTomography X-Ray ComputedbusinessSoftwareComputers in Biology and Medicine
researchProduct

The therapeutic impact of PET-FDG scanning in broncho-pulmonary cancer

2005

Because of the expected high performances of scintigraphic scans with [18F]-fluorodeoxyglucose (FDG) not only in diagnostics and but also in therapeutic impact, especially in thoracic oncology, there are a lot of French nuclear medicine departments which will soon be equipped with a positron emission tomograph (PET).The Nuclear Medicine Department of the Hôpital d'Instructions des Armées du Val-de-Grâce, Paris, led a retrospective study among physicians interested in 338 FDG-PET exams performed between may 2000 and march 2002 in order to compare its own results with international literature concerning four indications for lung cancer: pulmonary nodule or mass malignancy diagnostic, lung car…

Lung NeoplasmsPositron-Emission TomographySurveys and QuestionnairesBronchial NeoplasmsHumans[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineComputingMilieux_MISCELLANEOUSRetrospective Studies[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct

Comparison between whole-body MRI and PET/CT in staging newly diagnosed FDG-avid lymphomas: our experience.

2015

To compare whole body RMI (WB-RMI) and FDG-PET/CT for staging newly diagnosed FDG-avid lymphoma

Magnetic resonance imagingLymphomaStaging.Diffusion-weighted imagingPositron-emission tomographySettore MED/36 - Diagnostica Per Immagini E RadioterapiaComputed tomography
researchProduct

Functional Plasticity after Unilateral Vestibular Midbrain Infarction in Human Positron Emission Tomography.

2016

The aim of the study was to uncover mechanisms of central compensation of vestibular function at brainstem, cerebellar, and cortical levels in patients with acute unilateral midbrain infarctions presenting with an acute vestibular tone imbalance. Eight out of 17 patients with unilateral midbrain infarctions were selected on the basis of signs of a vestibular tone imbalance, e.g., graviceptive (tilts of perceived verticality) and oculomotor dysfunction (skew deviation, ocular torsion) in F18-fluordeoxyglucose (FDG)-PET at two time points: A) in the acute stage, and B) after recovery 6 months later. Lesion-behavior mapping analyses with MRI verified the exact structural lesion sites. Group su…

Male0301 basic medicineBrain Stem Infarctionslcsh:MedicinePathology and Laboratory MedicineMidbrainDiagnostic Radiology0302 clinical medicineThalamusMesencephalonCortex (anatomy)Medicine and Health SciencesMedicinelcsh:ScienceTomographyPostural BalanceVestibular systemNeuronal PlasticityMultidisciplinaryRadiology and ImagingBrainAnatomyFrontal eye fieldsMagnetic Resonance Imagingmedicine.anatomical_structureVestibular DiseasesInfarctionThalamic NucleiFemaleBrainstemAnatomyBrainstemResearch ArticleImaging TechniquesThalamusNeuroimagingResearch and Analysis Methods03 medical and health sciencesSigns and SymptomsDiagnostic MedicineOcular SystemHumansSkew deviationAgedbusiness.industrylcsh:RBiology and Life SciencesVestibular cortex030104 developmental biologyVisual cortexCase-Control StudiesPositron-Emission TomographyLesionsEyeslcsh:QbusinessHeadNeurosciencePositron Emission Tomography030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Effects of tetrahydrocannabinol on glucose uptake in the rat brain

2017

Δ9-Tetrahydrocannabinol (THC) is the psychoactive component of the plant Cannabis sativa and acts as a partial agonist at cannabinoid type 1 and type 2 receptors in the brain. The goal of this study was to assess the effect of THC on the cerebral glucose uptake in the rat brain. 21 male Sprague Dawley rats (12-13 w) were examined and received five different doses of THC ranging from 0.01 to 1 mg/kg. For data acquisition a Focus 120 small animal PET scanner was used and 24.1-28.0 MBq of [18F]-fluoro-2-deoxy-d-glucose were injected. The data were acquired for 70 min and arterial blood samples were collected throughout the scan. THC, THC-OH and THC-COOH were determined at 55 min p.i. Nine volu…

Male0301 basic medicineCannabinoid receptormedicine.medical_treatmentGlucose uptakeStimulationPharmacologyPartial agonistRats Sprague-Dawley03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineFluorodeoxyglucose F18Tandem Mass Spectrometrymental disordersmedicineAnimalsDronabinolTetrahydrocannabinolCannabinoid Receptor AgonistsPharmacologyBrain MappingPsychotropic DrugsDose-Response Relationship DrugChemistryorganic chemicalsBrainGlucose030104 developmental biologyPositron-Emission TomographyCerebellar cortexArterial bloodCannabinoidRadiopharmaceuticals030217 neurology & neurosurgeryChromatography Liquidmedicine.drugNeuropharmacology
researchProduct

Comparison of Different Hypotheses Regarding the Spread of Alzheimer’s Disease Using Markov Random Fields and Multimodal Imaging

2018

Alzheimer’s disease (AD) is characterized by a cascade of pathological processes that can be assessed in vivo using different neuroimaging methods. Recent research suggests a systematic sequence of pathogenic events on a global biomarker level, but little is known about the associations and dependencies of distinct lesion patterns on a regional level. Markov random fields are a probabilistic graphical modeling approach that represent the interaction between individual random variables by an undirected graph. We propose the novel application of this approach to study the interregional associations and dependencies between multimodal imaging markers of AD pathology and to compare different hy…

Male0301 basic medicineComputer scienceModels Neurologicalphysiopathology [Brain]Machine learningcomputer.software_genrephysiopathology [Alzheimer Disease]Multimodal Imaging03 medical and health sciences0302 clinical medicineNeuroimagingAlzheimer DiseaseHumansddc:610Graphical modeldiagnostic imaging [Brain]Default mode networkAgedModels StatisticalRandom fieldMarkov random fieldMarkov chainbusiness.industryGeneral NeuroscienceProbabilistic logicBrainGeneral MedicineMagnetic Resonance ImagingMarkov ChainsPsychiatry and Mental healthClinical Psychology030104 developmental biologyPositron-Emission TomographyGraph (abstract data type)FemaleArtificial intelligenceGeriatrics and Gerontologybusinessdiagnostic imaging [Alzheimer Disease]computer030217 neurology & neurosurgeryJournal of Alzheimer's Disease
researchProduct

Exosomal HSP70 for Monitoring of Frontotemporal Dementia and Alzheimer’s Disease: Clinical and FDG-PET Correlation

2019

We aimed to study the expression of circulating heat-shock protein HSP70 and exosomes in plasma of a cohort of patients with Alzheimer's disease (AD) and frontotemporal dementia (FTD) at different stages. We performed correlations with clinical scales and FDG-PET. HSP70 levels were higher within exosomes than free in plasma. Moderate correlations were found between exosomal HSP70 and CDR, FTLD-CDR, and extension of hypometabolism. Our results suggest modifications in the level of exosomal HSP70 during the course of neurodegeneration, regardless of AD or FTD, and therefore HSP70 could have a potential role in the follow-up of these disorders.

Male0301 basic medicineOncologymedicine.medical_specialtyDiseaseNeuropsychological TestsExosomesCorrelation03 medical and health sciences0302 clinical medicineAlzheimer DiseaseFluorodeoxyglucose F18Internal medicinemental disordersmedicineHumansHSP70 Heat-Shock ProteinsCorrelation of DataAgedbusiness.industryGeneral NeuroscienceNeurodegenerationGeneral Medicinemedicine.diseaseMicrovesiclesHsp70Psychiatry and Mental healthClinical Psychology030104 developmental biologyFrontotemporal DementiaPositron-Emission TomographyCohortFemaleRadiopharmaceuticalsGeriatrics and GerontologybusinessBiomarkers030217 neurology & neurosurgeryFrontotemporal dementiaJournal of Alzheimer's Disease
researchProduct

Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology

2018

Amyloid deposition and neurofibrillary degeneration in Alzheimer's disease specifically affect discrete neuronal systems, but the underlying mechanisms that render some brain regions more vulnerable to Alzheimer's disease pathology than others remain largely unknown. Here we studied molecular properties underlying these distinct regional vulnerabilities by analysing Alzheimer's disease-typical neuroimaging patterns of amyloid deposition and neurodegeneration in relation to regional gene expression profiles of the human brain. Graded patterns of brain-wide vulnerability to amyloid deposition and neurodegeneration in Alzheimer's disease were estimated by contrasting multimodal amyloid-sensiti…

Male0301 basic medicinePathologyphysiology [Amyloidogenic Proteins]genetics [Transcriptome]genetics [Alzheimer Disease]Cohort StudiesTranscriptomepathology [Alzheimer Disease]metabolism [Amyloidogenic Proteins]methods [Magnetic Resonance Imaging]0302 clinical medicinepathology [Brain]Gene expressiongenetics [Genetic Predisposition to Disease]Aged 80 and overmethods [Positron-Emission Tomography]NeurodegenerationBrainNeurofibrillary TanglesHuman brainMagnetic Resonance Imagingmetabolism [Neurofibrillary Tangles]medicine.anatomical_structureFemalemethods [Neuroimaging]Alzheimer's Disease Neuroimaging InitiativeAmyloidmedicine.medical_specialtyAmyloidmetabolism [Amyloid beta-Peptides]Amyloidogenic ProteinsNeuroimagingtau ProteinsBiology03 medical and health sciencesAlzheimer DiseasemedicineHumansDementiaGenetic Predisposition to Diseaseddc:610metabolism [Amyloid]AgedAmyloid beta-PeptidesCyclin-dependent kinase 5medicine.diseasemetabolism [tau Proteins]030104 developmental biologyPositron-Emission Tomographypathology [Neurofibrillary Tangles]Neurology (clinical)Transcriptome030217 neurology & neurosurgeryBrain
researchProduct

MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males

2016

A recent [F-18]FDOPA-PET study reports negative correlations between dopamine synthesis rates and aggressive behavior. Since dopamine is among the substrates for monoamine oxidase A (MAOA), this investigation examines whether functional allelic variants of the MAOA tandem repeat (VNTR) promotor polymorphism, which is known to modulate aggressive behavior, influences dopamine release and aggression in response to violent visual stimuli. We selected from a genetic prescreening sample, strictly case-matched groups of 2 x 12 healthy male subjects with VNTRs predictive of high (MAOA-High) and low (MAOA-Low) MAOA expression. Subjects underwent pairs of PET sessions (dopamine D-2/3 ligand [F-18]DM…

Male0301 basic medicinemedicine.medical_specialtyGenotypeCognitive NeuroscienceDopamineContext (language use)Polymorphism Single NucleotideDevelopmental psychologyYoung Adult03 medical and health sciences0302 clinical medicineDopaminePolymorphism (computer science)Dopamine receptor D2Internal medicineImage Processing Computer-AssistedmedicineHumansMAOAYoung adultMonoamine OxidasebiologyAggressionDopaminergicBrainDMFPAggression030104 developmental biologyEndocrinologyPETNeurologyPositron-Emission Tomographybiology.proteinmedicine.symptomMonoamine oxidase APsychology030217 neurology & neurosurgerymedicine.drug
researchProduct